SORBITAN MONOOLEATE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
429.0 4.0 3 6 96.0 18 0.88
UNII
06XEA2VD56
CAS
1338-43-8
SYNONYMS
  • Sorbitan Monooleate
  • Sorbitan Oleate
  • Span 80
  • Anhydrosorbitol Monooleate
  • Nsc-406239
  • Arlacel 80
  • Sorbitan Oleate [inn]
  • Sorbitan Monooleate [usan]
  • Sorbitan Oleate [ep]
  • Sorbitan Oleate [mart.]
  • Sorbitan Oleate [inci]
  • Sorbitan Monooleate [fcc]
  • Sorbitan Monooleate [ii]
  • Sorbitan Monooleate [hsdb]
  • Sorbitan Monooleate [vandf]
  • Sorbitan Mono-Oletae
  • Sorbitan Mono-Oletae [who-Dd]
  • E-494
  • Ins-494
  • Ins No.494
  • Sorbitan Esters Sorbitan Oleate [mi]
ZINC ID(s)
Availability
Present in 11 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Functions of Sorbitan Monooleate

Emul - Emulsifier

Dosages

Route Formulation Per Unit Dose
Rectal Suppository 22MG
Topical Cream, Augmented 0.2%
Topical Cream, Emulsion, Sustained Release 3.5%W/W
Topical Emulsion 2.5%
Topical Emulsion, Cream 3.5%
Topical Lotion 7%
Topical Ointment
Transdermal Film, Controlled Release
Oral Capsule 40MG
Oral Capsule, Soft Gelatin 153.9MG
Oral Capsule, Soft Gelatin Liquid-Filled 10MG
Oral Capsule, Sustained Action 1.7MG
Oral Emulsion
Oral Solution 15%
Oral Suspension
Oral Tablet 1.7MG
Oral Tablet, Coated 0.13MG
Oral Tablet, Delayed Action, Enteric Coated 1.89MG
Oral Tablet, Film Coated 0.69MG
Oral Tablet, Sustained Action 7.8MG
Oral Tablet, Sustained Action, Film Coated 1MG

More Information

Usage Over Time

Comments